Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.Coronavirus Omicron Variant, Clinical Trials, Vaccination and Immunization, Coronavirus (2019-nCoV), Research, Drugs (Pharmaceuticals), Johnson & Johnson, South AfricaRead More
